BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27336211)

  • 1. Does salpingectomy have a deleterious impact on ovarian response in in vitro fertilization cycles?
    Yoon SH; Lee JY; Kim SN; Chung HW; Park SY; Lee C
    Fertil Steril; 2016 Oct; 106(5):1083-1092.e5. PubMed ID: 27336211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of salpingectomy on ovarian response to hyperstimulation during in vitro fertilization: a meta-analysis.
    Fan M; Ma L
    Fertil Steril; 2016 Aug; 106(2):322-329.e9. PubMed ID: 27114330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live-birth rates in very poor prognosis patients, who are defined as poor responders under the Bologna criteria, with nonelective single embryo, two-embryo, and three or more embryos transferred.
    Gleicher N; Vega MV; Darmon SK; Weghofer A; Wu YG; Wang Q; Zhang L; Albertini DF; Barad DH; Kushnir VA
    Fertil Steril; 2015 Dec; 104(6):1435-41. PubMed ID: 26348275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis.
    Youssef MA; van Wely M; Mochtar M; Fouda UM; Eldaly A; El Abidin EZ; Elhalwagy A; Mageed Abdallah AA; Zaki SS; Abdel Ghafar MS; Mohesen MN; van der Veen F
    Fertil Steril; 2018 Feb; 109(2):289-301. PubMed ID: 29317127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
    Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
    Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
    Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
    Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased odds of live birth in fresh in vitro fertilization cycles with shorter ovarian stimulation.
    Pereira N; Friedman C; Hutchinson AP; Lekovich JP; Elias RT; Rosenwaks Z
    Fertil Steril; 2017 Jan; 107(1):104-109.e2. PubMed ID: 27793370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation.
    Tran ND; Aghajanova L; Kao CN; Cedars MI; Rosen MP
    Fertil Steril; 2016 Mar; 105(3):690-696. PubMed ID: 26696299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
    Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
    Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian Response and in Vitro Fertilization Outcomes After Salpingectomy: Does Salpingectomy Indication Matter?
    Pereira N; Pryor KP; Voskuilen-Gonzalez A; Lekovich JP; Elias RT; Spandorfer SD; Rosenwaks Z
    J Minim Invasive Gynecol; 2017; 24(3):446-454.e1. PubMed ID: 28069482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of salpingectomy on ovarian response in controlled ovarian hyperstimulation for in vitro fertilization: a reappraisal.
    Almog B; Wagman I; Bibi G; Raz Y; Azem F; Groutz A; Barkan G; Holzer H; Amit A; Tulandi T; Levin I
    Fertil Steril; 2011 Jun; 95(8):2474-6. PubMed ID: 21474129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ovarian response in fragile X patients and premutation carriers undergoing IVF-PGD: reappraisal.
    Avraham S; Almog B; Reches A; Zakar L; Malcov M; Sokolov A; Alpern S; Azem F
    Hum Reprod; 2017 Jul; 32(7):1508-1511. PubMed ID: 28472405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders--an observational pilot study.
    Mitri F; Behan LA; Murphy CA; Hershko-Klement A; Casper RF; Bentov Y
    Fertil Steril; 2016 Jan; 105(1):100-5.e1-6. PubMed ID: 26496380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpinges.
    Gelbaya TA; Nardo LG; Fitzgerald CT; Horne G; Brison DR; Lieberman BA
    Fertil Steril; 2006 May; 85(5):1464-8. PubMed ID: 16580673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.